Search results
9,154 Shares in GSK plc (NYSE:GSK) Bought by Virtu Financial LLC
ETF DAILY NEWS· 4 days agoVirtu Financial LLC acquired a new position in shares of GSK plc (NYSE:GSK – Free Report) in the fourth quarter, according to its most recent 13F filing ...
GSK plc (NYSE:GSK) Shares Acquired by First Hawaiian Bank
ETF DAILY NEWS· 4 days agoFirst Hawaiian Bank boosted its holdings in GSK plc (NYSE:GSK – Free Report) by 3.3% in the first quarter, according to the company in its most recent Form ...
Leo Wealth LLC Purchases New Shares in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 6 days agoLeo Wealth LLC purchased a new stake in GSK plc (NYSE:GSK – Free Report) during the 4th quarter, according to the company in its most recent filing with ...
Cwm LLC Cuts Stock Holdings in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 4 days agoCwm LLC trimmed its stake in shares of GSK plc (NYSE:GSK – Free Report) by 7.2% in the 1st quarter, according to its most recent disclosure with the SEC ...
NBC Securities Inc. Has $1.43 Million Stock Holdings in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 4 days agoNBC Securities Inc. trimmed its position in GSK plc (NYSE:GSK – Free Report) by 1.7% in the first quarter, according to the company in its most recent Form ...
GSK (LON:GSK) Given Underweight Rating at JPMorgan Chase & Co.
ETF DAILY NEWS· 5 days agoJPMorgan Chase & Co. reissued their underweight rating on shares of GSK (LON:GSK – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com ...
Will WHO’s new guidance spur hepatitis B immunisation?
Pharmaceutical Technology via Yahoo Finance· 3 days agoGlobalData is the parent company of Pharma Technology... through universal infant immunisation, HBV...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoThe vaccine, dubbed mResvia, was developed to protect people age 60 and older from RSV. Usually, RSV...
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
Zacks via Yahoo Finance· 6 days agoMerck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV...
Arcturus Therapeutics appoints Moncef Slaoui to board By Investing.com
Investing.com· 4 days ago(NASDAQ:ARCT), a biotechnology company specializing in mRNA medicines for infectious diseases and...